Decreased appetite is technically a side effect but also the primary mechanism through which weight loss occurs, so most people consider it a feature rather than a bug
Following GLP-1 deprescription, patients weight did not significantly increase at 6 or 12 months post deprescription, compared to many well-known drug trials (in red) where patients regain up to two thirds of weight loss after discontinuing the drug
Clinicians are familiar with the clinical features of the 2 most common drug-induced cutaneous reactions, morbilliform drug rash and urticarial rash 2 : Morbilliform drug rash, also called exanthematous or maculopapular drug eruption, is the most common, classically presenting with an erythematous maculopapular rash 1 to 2 weeks after a drug exposure Urticarial rash, the second most common, presents as annular, pruritic, migratory plaques usually within hours of initial drug exposure
PMID: 38999294
Also advise of any health or medication changes